Expanding FlevoBESS And Enexis Projects To Address Future Energy Needs

Published
09 Feb 25
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
€12.10
5.0% undervalued intrinsic discount
14 Aug
€11.50
Loading
1Y
-26.8%
7D
-0.6%

Author's Valuation

€12.1

5.0% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 23%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Decreased 0.63%

AnalystConsensusTarget has decreased revenue growth from 8.3% to 7.2%.

Shared on19 Mar 25
Fair value Increased 31%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Decreased 3.89%